Lung cancer, arthritis and gout: reports from ASCO and EULAR

The second most common cancer diagnosed in the UK, lung cancer, is also the most deadly. Over twothirds of patients present with advanced disease, and at present only 7% survive for at least five years after diagnosis.¹ New hope is offered by studies presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO), held on 28 May–2 June in Orlando, USA Copyright © 2009 John Wiley & Sons, Ltd.